Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis

被引:58
作者
Möllers, M
Aries, SP
Drömann, D
Mascher, B
Braun, J
Dalhoff, K
机构
[1] Med Univ Lubeck, Dept Med 2, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Dept Immunol, D-23538 Lubeck, Germany
关键词
sarcoidosis; Th1/Th2; cytokines; flow cytometry;
D O I
10.1136/thorax.56.6.487
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background-Pulmonary sarcoidosis is characterised by a mononuclear alveolitis with a predominance of CD4+ T cells and macrophages. We determined the intracellular expression of interferon (IFN)gamma, interleukin (IL)-2, tumour necrosis factor (TNF)alpha, IL-4, IL-5 and IL-10 in CD4+ and CD8+, naive and memory lymphocytes from blood and bronchoalveolar lavage (BAL) fluid using three colour flow cytometry. Methods-Eighteen untreated patients with pulmonary sarcoidosis were evaluated and stratified according to whether they had acute or chronic disease. Results-Significantly more T cells expressed Th1 than Th2 type cytokines in both BAL fluid and peripheral blood samples, regardless of clinical presentation. Significantly greater proportions of T cells secreted Th1 type cytokines in BAL fluid than in peripheral blood. Thl type cytokines were more frequently expressed by peripheral and alveolar T cells in acute disease than in chronic disease. There were no significant differences between CD4+ and CD8+ T cells. Concerning naive and memory lymphocytes, significantly higher CD45RO:CD45RA ratios were found in BAL fluid than in blood, and increased expression of Th2 type cytokines was found in peripheral compared with alveolar memory T cells. Conclusions-Our data support the immunopathogenetic concept of Th1/Th2 imbalance and compartmentalisation in pulmonary sarcoidosis and suggest that the cytokine patterns change during the course of disease. Expression of Th2 type cytokines in memory lymphocytes is decreased in the alveolar compartment compared with peripheral blood.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 30 条
[1]   CD8 ALVEOLITIS IN SARCOIDOSIS - INCIDENCE, PHENOTYPIC CHARACTERISTICS, AND CLINICAL-FEATURES [J].
AGOSTINI, C ;
TRENTIN, L ;
ZAMBELLO, R ;
BULIAN, P ;
SIVIERO, F ;
MASCIARELLI, M ;
FESTI, G ;
CIPRIANI, A ;
SEMENZATO, G .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (05) :466-472
[2]   Sarcoidosis news: Immunologic frontiers for new immunosuppressive strategies [J].
Agostini, C ;
Costabel, U ;
Semenzato, G .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 88 (02) :199-204
[3]   Th1-Th2: reliable paradigm or dangerous dogma? [J].
Allen, JE ;
Maizels, RM .
IMMUNOLOGY TODAY, 1997, 18 (08) :387-392
[4]  
Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO
[5]  
2-L
[6]  
Baumer I, 1997, AM J RESP CELL MOL, V16, P171
[7]   HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis [J].
Berlin, M ;
FogdellHahn, A ;
Olerup, O ;
Eklund, A ;
Grunewald, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (05) :1601-1605
[8]  
Drent M, 1997, SARCOIDOSIS VASC DIF, V14, P31
[9]  
FAZEL SB, 1994, CLIN EXP IMMUNOL, V95, P509
[10]  
HOSHINO T, 1995, CLIN EXP IMMUNOL, V102, P399